Update of package insert - Eraxis 100mg Powder for Injection (Anidulafungin): Do not freeze (reconstituted) infusion solution
Healthcare professional
Industry member
Therapeutic Products
7 September 2020
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
A Dear Healthcare Professional Letter has been issued by Pfizer to inform healthcare professionals of the change in the storage condition for the (reconstituted) infusion solution of Eraxis 100mg Powder for Injection. According to the newly approved prescribing information, the (reconstituted) infusion solution should not be frozen. Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
